Financial incentives and treatment patterns in cancer medicine: Evidence from German claims data on pembrolizumab and radiotherapy
Aufenberg B, Brei G, König J, Sommerlatte S, Mehlis K, Schildmann J, Winkler E, Greiner W (2026)
Oncology Research and Treatment 49(Suppl. 1): 19.
Kurzbeitrag Konferenz / Poster
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Aufenberg, BirtheUniBi;
Brei, GereonUniBi 
;
König, Julia;
Sommerlatte, Sabine;
Mehlis, Katja;
Schildmann, Jan;
Winkler, Eva;
Greiner, WolfgangUniBi
;
König, Julia;
Sommerlatte, Sabine;
Mehlis, Katja;
Schildmann, Jan;
Winkler, Eva;
Greiner, WolfgangUniBiEinrichtung
Erscheinungsjahr
2026
Serien- oder Zeitschriftentitel
Oncology Research and Treatment
Band
49
Ausgabe
Suppl. 1
Seite(n)
19
Konferenz
37. Deutscher Krebskongress
Konferenzort
Berlin
Konferenzdatum
2026-02-18 – 2026-02-21
ISSN
2296-5270
eISSN
2296-5262
Page URI
https://pub.uni-bielefeld.de/record/3016659
Zitieren
Aufenberg B, Brei G, König J, et al. Financial incentives and treatment patterns in cancer medicine: Evidence from German claims data on pembrolizumab and radiotherapy. Oncology Research and Treatment. 2026;49(Suppl. 1):19.
Aufenberg, B., Brei, G., König, J., Sommerlatte, S., Mehlis, K., Schildmann, J., Winkler, E., et al. (2026). Financial incentives and treatment patterns in cancer medicine: Evidence from German claims data on pembrolizumab and radiotherapy. Oncology Research and Treatment, 49(Suppl. 1), 19.
Aufenberg, Birthe, Brei, Gereon, König, Julia, Sommerlatte, Sabine, Mehlis, Katja, Schildmann, Jan, Winkler, Eva, and Greiner, Wolfgang. 2026. “Financial incentives and treatment patterns in cancer medicine: Evidence from German claims data on pembrolizumab and radiotherapy”, Oncology Research and Treatment, 49 (Suppl. 1): 19.
Aufenberg, B., Brei, G., König, J., Sommerlatte, S., Mehlis, K., Schildmann, J., Winkler, E., and Greiner, W. (2026). Financial incentives and treatment patterns in cancer medicine: Evidence from German claims data on pembrolizumab and radiotherapy. Oncology Research and Treatment 49, 19.
Aufenberg, B., et al., 2026. Financial incentives and treatment patterns in cancer medicine: Evidence from German claims data on pembrolizumab and radiotherapy. Oncology Research and Treatment, 49(Suppl. 1), p 19.
B. Aufenberg, et al., “Financial incentives and treatment patterns in cancer medicine: Evidence from German claims data on pembrolizumab and radiotherapy”, Oncology Research and Treatment, vol. 49, 2026, pp. 19.
Aufenberg, B., Brei, G., König, J., Sommerlatte, S., Mehlis, K., Schildmann, J., Winkler, E., Greiner, W.: Financial incentives and treatment patterns in cancer medicine: Evidence from German claims data on pembrolizumab and radiotherapy. Oncology Research and Treatment. 49, 19 (2026).
Aufenberg, Birthe, Brei, Gereon, König, Julia, Sommerlatte, Sabine, Mehlis, Katja, Schildmann, Jan, Winkler, Eva, and Greiner, Wolfgang. “Financial incentives and treatment patterns in cancer medicine: Evidence from German claims data on pembrolizumab and radiotherapy”. Oncology Research and Treatment 49.Suppl. 1 (2026): 19.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Suchen in
Google Scholar